Cargando…
Non-viral TRAC-knocked-in CD19(KI)CAR-T and gp350(KI)CAR-T cells tested against Burkitt lymphomas with type 1 or 2 EBV infection: In vivo cellular dynamics and potency
INTRODUCTION: The ubiquitous Epstein–Barr virus (EBV) is an oncogenic herpes virus associated with several human malignancies. EBV is an immune-evasive pathogen that promotes CD8(+) T cell exhaustion and dysregulates CD4(+) T cell functions. Burkitt lymphoma (BL) is frequently associated with EBV in...
Autores principales: | Braun, Tobias, Pruene, Alina, Darguzyte, Milita, vom Stein, Alexander F., Nguyen, Phuong-Hien, Wagner, Dimitrios L., Kath, Jonas, Roig-Merino, Alicia, Heuser, Michael, Riehm, Lucas L., Schneider, Andreas, Awerkiew, Sabine, Talbot, Steven R., Bleich, André, Figueiredo, Constanca, Bornhäuser, Martin, Stripecke, Renata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081580/ https://www.ncbi.nlm.nih.gov/pubmed/37033919 http://dx.doi.org/10.3389/fimmu.2023.1086433 |
Ejemplares similares
-
Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells
por: Kath, Jonas, et al.
Publicado: (2022) -
CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease
por: Slabik, Constanze, et al.
Publicado: (2020) -
GMP development and preclinical validation of CAR-T cells targeting a lytic EBV antigen for therapy of EBV-associated malignancies
por: Zhang, Xi, et al.
Publicado: (2023) -
To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021) -
Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)